ALERTS & COVID-19 UPDATES Learn more: COVID-19 Resources; COVID-19 Testing; Vaccine Info; Visitor Policy; Support Us

[LCID Study Number: 20193125]

NRG-GU006, A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy With or Without Enhanced Anti-Androgen Therapy With Apalutamide in Recurrent Prostate Cancer

The purpose of this study is to compare any good and bad effects of using the drug apalutamide along with usual radiation therapy to using usual radiation therapy alone.

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-3421